
Robert E. Mosser
Examiner (ID: 16617, Phone: (571)272-4451 , Office: P/3714 )
| Most Active Art Unit | 3715 |
| Art Unit(s) | 3714, 3715, 3713, 3712 |
| Total Applications | 839 |
| Issued Applications | 347 |
| Pending Applications | 141 |
| Abandoned Applications | 372 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9060004
[patent_doc_number] => 08546439
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-10-01
[patent_title] => 'Small molecule inhibitors of retroviral assembly and maturation'
[patent_app_type] => utility
[patent_app_number] => 13/616710
[patent_app_country] => US
[patent_app_date] => 2012-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 11
[patent_no_of_words] => 10663
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13616710
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/616710 | Small molecule inhibitors of retroviral assembly and maturation | Sep 13, 2012 | Issued |
Array
(
[id] => 9042478
[patent_doc_number] => 20130245116
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-19
[patent_title] => 'COMPOSITIONS AND METHODS FOR THE DISRUPTION OF MYCOBACTERIUM BIOFILM'
[patent_app_type] => utility
[patent_app_number] => 13/611834
[patent_app_country] => US
[patent_app_date] => 2012-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 14810
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13611834
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/611834 | COMPOSITIONS AND METHODS FOR THE DISRUPTION OF MYCOBACTERIUM BIOFILM | Sep 11, 2012 | Abandoned |
Array
(
[id] => 8721333
[patent_doc_number] => 20130072550
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-21
[patent_title] => 'PKC ACTIVATION AS A MEANS FOR ENHANCING sAPPalpha SECRETION AND IMROVING COGNITION USING BRYOSTATIN TYPE COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/608874
[patent_app_country] => US
[patent_app_date] => 2012-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 12115
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13608874
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/608874 | PKC ACTIVATION AS A MEANS FOR ENHANCING sAPPalpha SECRETION AND IMROVING COGNITION USING BRYOSTATIN TYPE COMPOUNDS | Sep 9, 2012 | Abandoned |
Array
(
[id] => 10974184
[patent_doc_number] => 20140377219
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-25
[patent_title] => 'HIV INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 14/241329
[patent_app_country] => US
[patent_app_date] => 2012-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 31456
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 33
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14241329
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/241329 | HIV inhibitors | Sep 5, 2012 | Issued |
Array
(
[id] => 8932687
[patent_doc_number] => 08492386
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-07-23
[patent_title] => 'Methods for treating HCV'
[patent_app_type] => utility
[patent_app_number] => 13/603006
[patent_app_country] => US
[patent_app_date] => 2012-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 59217
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13603006
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/603006 | Methods for treating HCV | Sep 3, 2012 | Issued |
Array
(
[id] => 8780550
[patent_doc_number] => 20130102525
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-25
[patent_title] => 'Methods for Treating HCV'
[patent_app_type] => utility
[patent_app_number] => 13/603022
[patent_app_country] => US
[patent_app_date] => 2012-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 62872
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13603022
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/603022 | Methods for treating HCV | Sep 3, 2012 | Issued |
Array
(
[id] => 8792706
[patent_doc_number] => 20130109675
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-02
[patent_title] => 'OXAZOLE AND THIAZOLE COMPOUNDS AS BETA-CATENIN MODULATORS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/595336
[patent_app_country] => US
[patent_app_date] => 2012-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 31195
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13595336
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/595336 | Oxazole and thiazole compounds as β-catenin modulators and uses thereof | Aug 26, 2012 | Issued |
Array
(
[id] => 9958024
[patent_doc_number] => 09006230
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-04-14
[patent_title] => '1,6-diazabicyclo [3,2,1] octan-7-one derivatives and their use in the treatment of bacterial infections'
[patent_app_type] => utility
[patent_app_number] => 14/113980
[patent_app_country] => US
[patent_app_date] => 2012-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21554
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14113980
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/113980 | 1,6-diazabicyclo [3,2,1] octan-7-one derivatives and their use in the treatment of bacterial infections | Aug 23, 2012 | Issued |
Array
(
[id] => 9009421
[patent_doc_number] => 08524719
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-09-03
[patent_title] => 'Therapeutic compounds for blocking DNA synthesis of pox viruses'
[patent_app_type] => utility
[patent_app_number] => 13/590667
[patent_app_country] => US
[patent_app_date] => 2012-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 18
[patent_no_of_words] => 26582
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13590667
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/590667 | Therapeutic compounds for blocking DNA synthesis of pox viruses | Aug 20, 2012 | Issued |
Array
(
[id] => 16381901
[patent_doc_number] => 10806711
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-20
[patent_title] => Method of treating acute decompensated heart failure with probenecid
[patent_app_type] => utility
[patent_app_number] => 13/584713
[patent_app_country] => US
[patent_app_date] => 2012-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 49
[patent_no_of_words] => 12538
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13584713
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/584713 | Method of treating acute decompensated heart failure with probenecid | Aug 12, 2012 | Issued |
Array
(
[id] => 8649586
[patent_doc_number] => 20130035315
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-07
[patent_title] => 'CRYSTALLIZATION METHOD AND BIOAVAILABILITY'
[patent_app_type] => utility
[patent_app_number] => 13/567827
[patent_app_country] => US
[patent_app_date] => 2012-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 47
[patent_figures_cnt] => 47
[patent_no_of_words] => 71090
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13567827
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/567827 | Crystallization method and bioavailability | Aug 5, 2012 | Issued |
Array
(
[id] => 8496531
[patent_doc_number] => 20120295939
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-22
[patent_title] => 'ANTI-VIRAL AGENT'
[patent_app_type] => utility
[patent_app_number] => 13/562068
[patent_app_country] => US
[patent_app_date] => 2012-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4999
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13562068
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/562068 | ANTI-VIRAL AGENT | Jul 29, 2012 | Abandoned |
Array
(
[id] => 8490083
[patent_doc_number] => 20120289490
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-15
[patent_title] => 'COMPOSITIONS AND METHODS FOR ENHANCING CORTICOSTEROID DELIVERY'
[patent_app_type] => utility
[patent_app_number] => 13/561277
[patent_app_country] => US
[patent_app_date] => 2012-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2981
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13561277
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/561277 | COMPOSITIONS AND METHODS FOR ENHANCING CORTICOSTEROID DELIVERY | Jul 29, 2012 | Abandoned |
Array
(
[id] => 8767039
[patent_doc_number] => 20130095076
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-18
[patent_title] => 'Methods For Increasing Blood Flow And/Or Promoting Tissue Regeneration'
[patent_app_type] => utility
[patent_app_number] => 13/542612
[patent_app_country] => US
[patent_app_date] => 2012-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 20841
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13542612
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/542612 | Methods For Increasing Blood Flow And/Or Promoting Tissue Regeneration | Jul 4, 2012 | Abandoned |
Array
(
[id] => 11790049
[patent_doc_number] => 09399619
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-07-26
[patent_title] => 'Sulfamoylbenzamide derivatives as antiviral agents against HBV infection'
[patent_app_type] => utility
[patent_app_number] => 14/130140
[patent_app_country] => US
[patent_app_date] => 2012-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12971
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14130140
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/130140 | Sulfamoylbenzamide derivatives as antiviral agents against HBV infection | Jun 28, 2012 | Issued |
Array
(
[id] => 9450070
[patent_doc_number] => 20140121240
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-01
[patent_title] => 'NOVEL PHARMACEUTICAL COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 14/129615
[patent_app_country] => US
[patent_app_date] => 2012-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5607
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14129615
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/129615 | NOVEL PHARMACEUTICAL COMPOSITION | Jun 25, 2012 | Abandoned |
Array
(
[id] => 8713362
[patent_doc_number] => 08399502
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-03-19
[patent_title] => 'Analogs of indole-3-carbinol and their use as agents against infection'
[patent_app_type] => utility
[patent_app_number] => 13/533910
[patent_app_country] => US
[patent_app_date] => 2012-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46534
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13533910
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/533910 | Analogs of indole-3-carbinol and their use as agents against infection | Jun 25, 2012 | Issued |
Array
(
[id] => 9491753
[patent_doc_number] => 20140142159
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-22
[patent_title] => 'COMPOUNDS FOR THE TREATMENT OF CANCERS ASSOCIATED WITH HUMAN PAPILLOMAVIRUS'
[patent_app_type] => utility
[patent_app_number] => 14/127675
[patent_app_country] => US
[patent_app_date] => 2012-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9496
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14127675
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/127675 | COMPOUNDS FOR THE TREATMENT OF CANCERS ASSOCIATED WITH HUMAN PAPILLOMAVIRUS | Jun 21, 2012 | Abandoned |
Array
(
[id] => 8638142
[patent_doc_number] => 20130029944
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-31
[patent_title] => 'INHIBITORS OF PROTEIN KINASES'
[patent_app_type] => utility
[patent_app_number] => 13/528709
[patent_app_country] => US
[patent_app_date] => 2012-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 66
[patent_figures_cnt] => 66
[patent_no_of_words] => 74212
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13528709
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/528709 | Inhibitors of protein kinases | Jun 19, 2012 | Issued |
Array
(
[id] => 8671478
[patent_doc_number] => 20130046016
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-21
[patent_title] => 'METHOD FOR LOWERING CHOLESTEROL'
[patent_app_type] => utility
[patent_app_number] => 13/526197
[patent_app_country] => US
[patent_app_date] => 2012-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 33185
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13526197
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/526197 | Method for lowering cholesterol | Jun 17, 2012 | Issued |